Surgical Protocol for Prevention of Mucositis

NCT ID: NCT04628520

Last Updated: 2020-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-02

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal of implant therapy is to obtain long-term peri-implant health. Among local risk factors in the etiology of peri-implant diseases the absence of keratinized tissue (KT) around the implant has been reported. In fact, a certain amount of KT width, providing better sensory isolation and, hence, less pain discomfort during brushing, may be useful to facilitate plaque control. A good plaque control should maintain periimplant health during time.

A very recent systematic review assessed the effect of soft tissue grafting procedures on peri-implant health, revealing that soft tissue grafting using autogenous tissue for gain of KT results in a significant decrease of PI, BOP and GI values and significantly lower PI and GI values and higher marginal bone levels at the study endpoint compared to maintenance groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based in the available data in literature, it has been demonstrated that the level of brushing discomfort was significantly higher in sites with \<2 mm of KT width, which exhibited more plaque and more bleeding on probing than sites with ≥2 mm of KT width. Therefore, various procedures and materials were proposed in the past to augment the soft tissues around dental implant. Soft-tissue grafting seems beneficial, especially in posterior mandible, when patients complains of soreness during oral hygiene procedures and plaque control is less than ideal and it may be facilitated by a better topography. The surgical procedures most frequently used to increase the width of keratinized tissue around an implant-supported restoration include an apically positioned split-flap/vestibuloplasty (APF) with or without the application of autogenous tissue (i.e., free gingival graft) or a xenogeneic collagen matrix.

However, it remains unclear whether or not surgical procedures for gain of KT may establish peri-implant health limiting the incidence of peri-implant disease and may positively affect self-performed oral hygiene measures reducing peri-implant soft tissue inflammation when compared with non-augmented, inadequately dimensioned implant sites. Neither do clinical suggestions exist for a specific soft tissue transplant to obtain more favorable outcomes.

The aim of the present randomized controlled clinical trial is to assess the effect of soft tissue augmentation procedures at diseased (mucositis) implant sites in terms of:

* occurrence of peri-implant health (absence of BoP/suppuration, PPD\>6mm, longitudinal radiographic bone loss) at 3, 6 and 12 months
* reduction of BoP (%) at 3, 6 and 12 months
* marginal bone loss (MBL) at 12 months
* improvement of self-performed oral hygiene measures (PI, VAS) at 3, 6 and 12 months and post-operative morbidity (VAS) at 7 days.
* change in tissue morphology: increase of KT width (2D in mm.) and tissue volume (volumetric 3D) at 3, 6 and 12 months and aesthetic (blinder examiner) at 6, 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mucositis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

CTG Mucositis Surgical Treatment Keratinised tissue Free gingival graft Collagen matrix

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maintenance

Oral hygiene instruction and periodontal maintenance

Group Type SHAM_COMPARATOR

Maintenance

Intervention Type PROCEDURE

Oral Hygiene Instruction, periodontal debridment and Supportive Periodontal Therapy

Free gingival graft

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive a free gingival graft (FGG) harvested from the palate, that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Group Type ACTIVE_COMPARATOR

Free gingival graft

Intervention Type PROCEDURE

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive a free gingival graft (FGG) harvested from the palate, that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Maintenance

Intervention Type PROCEDURE

Oral Hygiene Instruction, periodontal debridment and Supportive Periodontal Therapy

Collagen matrix

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive either a collagen matrix (CM), that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Group Type ACTIVE_COMPARATOR

Collagen matrix

Intervention Type PROCEDURE

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive either a collagen matrix (CM), that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Maintenance

Intervention Type PROCEDURE

Oral Hygiene Instruction, periodontal debridment and Supportive Periodontal Therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Free gingival graft

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive a free gingival graft (FGG) harvested from the palate, that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Intervention Type PROCEDURE

Collagen matrix

After administration of local anesthesia, an intrasulcular incision will be made at the muco-gingival line and a partial thickness flap will be raised and sutured at the base of the newly created vestibule with resorbable mattress sutures. After the completion of the apically positioned flap, patients will receive either a collagen matrix (CM), that will be fixed with interrupted resorbable sutures to the recipient periosteal bed, free of any muscle attachment.

Intervention Type PROCEDURE

Maintenance

Oral Hygiene Instruction, periodontal debridment and Supportive Periodontal Therapy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemic healthy patients
* appropriate oral hygiene standards (full mouth plaque scores \<20%)
* periodontal health (BoP \< 10%) or gingivitis (BoP \> 10%) in a healthy or reduced periodontium
* clinical signs of mucositis (presence of BoP) at the affected implant-supported fixed prosthesis
* \< 2mm of KT at the mid-buccal aspect of implant-supported fixed prosthesis
* \< 10 cigarette/die

Exclusion Criteria

* any systemic disease that would negatively influence wound healing or known allergy to collagen
* more than 10 cigarettes/day
* sites with implant-supported rehabilitations presenting poor marginal adaptation (confirmed by an explorative probe and radiographic examination)
* implant-supported rehabilitations with inadequate access to hygiene
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Università Vita-Salute San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marco Clementini

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Massimo De Sanctis

Role: STUDY_CHAIR

Università Vita-Salute San Raffaele

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Università Vita-Salute San Raffaele

Milan, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marco Clementini

Role: CONTACT

Phone: 0226432806

Email: [email protected]

Massimo De Sanctis

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marco Clementini

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mucositis surgical

Identifier Type: -

Identifier Source: org_study_id